News from biotronik A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

May 21, 2019, 11:06 ET Late-Breaking Data at EuroPCR: BIOTRONIK's Orsiro Demonstrates Unique Benefits in Small Vessels

Focusing on patients with small vessels, three-year outcomes of the BIO-RESORT randomized controlled trial (RCT) showed a significantly lower target...


May 06, 2019, 10:00 ET Focusing on Women: BIOTRONIK Launches Study to Understand the Impact of ICDs in NICM Patients

BIOTRONIK today announced initial enrollment into the BIO-LIBRA study, a first-of-its kind, large-scale prospective study to analyze sex-specific...


Apr 29, 2019, 10:03 ET US Physicians Now Treating Patients with BIOTRONIK's Ultraslim Acticor DX Devices

BIOTRONIK today announced the full commercial launch of the Acticor device family, including Acticor DX and CRT-DX devices. Leading...


Apr 10, 2019, 10:03 ET BIOTRONIK Launches PK Papyrus Covered Coronary Stent in the US

BIOTRONIK today announced the United States (US) commercial launch of the PK Papyrus® covered coronary stent system for use in the emergency...


Mar 14, 2019, 13:57 ET FDA Approves Industry's Smallest, Slimmest 3T Tachycardia Devices from BIOTRONIK

BIOTRONIK today announced FDA approval of the Acticor and Rivacor high-voltage cardiac rhythm management (CRM) device families for treatment of...


Feb 22, 2019, 12:10 ET FDA Approves BIOTRONIK's Ultrathin Orsiro Stent for the Treatment of Coronary Artery Disease

BIOTRONIK today announced FDA approval of the Orsiro drug-eluting stent (DES) system. Orsiro is the first and only ultrathin DES to outperform the...


Sep 24, 2018, 10:03 ET TCT Congress 2018: BIOTRONIK's Orsiro Ultrathin Drug-Eluting Stent Further Outperforms Xience at Two-Year Follow-Up

Today, BIOTRONIK announced two-year data from the BIOFLOW-V randomized trial comparing the Orsiroa and Xienceb drug-eluting stents (DES). The data...


Sep 14, 2018, 13:26 ET Every Second Counts: BIOTRONIK's PK Papyrus Stent for Coronary Perforations Approved for Use in the US

BIOTRONIK today announced the FDA approval of the PK Papyrus covered coronary stent system under Humanitarian Device Exemption for use in the...


Aug 27, 2018, 10:46 ET BIOTRONIK Advances Arrhythmia Detection and Diagnosis with MoMe Cardiac Monitor in the US

BIOTRONIK today announced that the company is now the exclusive US distributor for InfoBionic's MoMe Kardia external cardiac diagnostic monitor. The...


Apr 03, 2018, 10:05 ET Improving Cardiology Care: BIOTRONIK US to Distribute Aziyo ECM Envelopes

BIOTRONIK US and Aziyo today announced a strategic agreement allowing BIOTRONIK to distribute Aziyo's CanGaroo® extracellular matrix (ECM)...


Mar 07, 2018, 10:05 ET Innovation that Matters: SXSW Selects BIOTRONIK MRI AutoDetect as Innovation Awards Finalist

BIOTRONIK today announced the company's MRI AutoDetect technology has been named a finalist in the 2018 South by Southwest® (SXSW®) Conference &...


Aug 28, 2017, 09:57 ET ESC Congress 2017: BIOTRONIK's Orsiro Drug-Eluting Stent Outperforms Xience in BIOFLOW-V Trial

BIOTRONIK today announced data from the BIOFLOW-V randomized trial comparing Orsiro* and Xience** drug-eluting stents (DES) with 12-month target...


Aug 21, 2017, 10:03 ET BIOTRONIK US Launches Smallest MR Conditional Quadripolar Cardiac Resynchronization Therapy Pacemaker

BIOTRONIK today announced FDA approval and commercial availability of Edora HF-T QP, an MR conditional quadripolar (QP) cardiac resynchronization...


Jul 19, 2017, 10:30 ET Fewer Leads, Fewer Complications: BIOTRONIK US Launches Proven DX Technology for Heart Failure Patients

BIOTRONIK today announced FDA approval and availability of the Intica DX and Intica cardiac resynchronization therapy (CRT)-DX implantable...


Jul 03, 2017, 10:00 ET BIOTRONIK US Announces Pivotal Trial Results of the Pulsar-18 Stent with 4-French Delivery System

BIOTRONIK today announced the results of the BIOFLEX-I clinical study and availability of Pulsar®-18 for the treatment of patients with peripheral...


Jun 07, 2017, 10:30 ET BIOTRONIK Launches Edora Pacemaker Series with MRI AutoDetect Technology

BIOTRONIK today announced the availability of the Edora line of devices, the company's first available pacemaker series featuring BIOTRONIK's MRI...


May 08, 2017, 13:55 ET BIOTRONIK Announces FDA Approval of MultiPole Pacing with ProMRI: 360° Solutions for Patients with Heart Failure

BIOTRONIK today announced FDA approval of the company's MultiPole Pacing (MPP) technology, providing physicians with additional treatment options for ...


May 08, 2017, 13:23 ET BIOTRONIK Receives FDA Approval for Sentus ProMRI Quadripolar Left Ventricular Lead

BIOTRONIK today announced FDA approval and the launch of Sentus ProMRI®, the thinnest quadripolar left ventricular lead available in the United...


May 08, 2017, 13:23 ET BIOTRONIK Launches First FDA Approved CRM Devices with MRI AutoDetect Technology

BIOTRONIK today announced the availability of the first FDA approved cardiac rhythm management (CRM) devices with technology that automatically...


Apr 18, 2017, 10:11 ET BIOTRONIK Introduces Smallest MR Conditional Defibrillator Lead in the US

After nearly a decade of research and development, BIOTRONIK today announced the launch of Plexa ProMRI®, the smallest (7.8F) MR conditional...


Feb 15, 2017, 09:42 ET FDA Approval Granted for BIOTRONIK's Ultra-Thin PRO-Kinetic Energy Cobalt Chromium Coronary Stent System

PRO-Kinetic Energy Cobalt Chromium (CoCr) Coronary Stent System from BIOTRONIK gained FDA approval utilizing results from the BIOHELIX-I clinical...


Nov 07, 2016, 10:15 ET BIOTRONIK Launches First and Only 42 Joule Ultra-High Energy ICD for Heart Failure Patients

BIOTRONIK today announced the launch of Inventra HF-T, the first and only implantable cardioverter defibrillator (ICD) available in the United States ...


Jun 16, 2016, 10:00 ET BIOTRONIK Launches Smallest MR Conditional Pacing Lead Available in the United States

BIOTRONIK announced today the commercial launch of Solia S ProMRI®, with a 5.6 French lead body, the smallest MR conditional pacing lead available in ...


May 24, 2016, 10:10 ET BIOTRONIK Launches CardioMessenger Smart Portable Device For Pacemaker and ICD Patients

BIOTRONIK, a global leader in cardio- and endovascular medical technology, today announced the launch of CardioMessenger Smart in the United States....


May 03, 2016, 10:50 ET Heart Rhythm 2016: BIOTRONIK Provides a Forum for Physicians to Discuss the Importance of Extending Care Beyond the Implant

BIOTRONIK will be exhibiting and initiating discussion about the importance of extending care beyond the implant at the Heart Rhythm Society's 37th...